Inhibitory Antibodies
-
F1912 Anti-ALCAM/CD166 Antibody (Praluzatamab-MMAE)Summary: Anti-ALCAM/CD166 Antibody (Praluzatamab-MMAE) -
F1913 Anti-ALP Antibody (Seagen Patent Anti-Alpp)Summary: Anti-ALP Antibody (Seagen Patent Anti-Alpp) -
F1914 Anti-AMHR2 Antibody (Murlentamab-MMAE)Summary: Anti-AMHR2 Antibody (Murlentamab-MMAE) -
F1915 Anti-Amyloid Beta Antibody (Amgen patent anti-beta amyloid)Summary: Anti-Amyloid Beta Antibody (Amgen patent anti-beta amyloid) -
F1916 Anti-Amyloid Beta Antibody (Georgetown U. patent anti-Amyloid Beta)Summary: Anti-Amyloid Beta Antibody (Georgetown U. patent anti-Amyloid Beta) -
F1917 Anti-Amyloid Beta Antibody (Kumamoto U. patent anti-Amyloid Beta)Summary: Anti-Amyloid Beta Antibody (Kumamoto U. patent anti-Amyloid Beta) -
F1918 Anti-Amyloid Beta AntibodySummary: Anti-Amyloid Beta Antibody -
F1919 Anti-Amyloid Beta Antibody (Rockefeller U. patent anti-Amyloid Beta)Summary: Anti-Amyloid Beta Antibody (Rockefeller U. patent anti-Amyloid Beta) -
F1920 Anti-Amyloid Beta Antibody (U.Zurich patent anti-Amyloid Beta)Summary: Anti-Amyloid Beta Antibody (U.Zurich patent anti-Amyloid Beta) -
F1921 Anti-ANGPT2 Antibody (Roche patent anti-ANG-2)Summary: Anti-ANGPT2 Antibody (Roche patent anti-ANG-2)
